EntreMed, Inc. (ENMD) Reports Fourth Quarter and Year-End 2012 Financial Results and Business Outlook For 2013
3/21/2013 7:00:29 AM
ROCKVILLE, Md., March 21, 2013 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD),
a clinical-stage pharmaceutical company developing therapeutics for the
treatment of cancer, today reported results for the three months and twelve
months ended December 31, 2012.